Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne.

Tan, Jerry; Thiboutot, D.; Popp, G.; Gooderham, M.; Lynde, C.; D. Del Rosso, J.; Weiss, J.; Blume-Peytavi, U.; Weglovska, Jolanta; M. Johnson, Sandra; Parish, L.; Witkowska, D.; Sanchez Colon, Nestor; A. Alió Saenz, A.; Ahmad, F.; Graeber, M.; S. Stein Gold, L.

doi:10.1016/j.jaad.2019.02.044

Public

Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne.

Shared by NobleBlocks on Jun 1, 2019 • 12:00 AM UTC

Authors:

Jerry Tan

D. Thiboutot

G. Popp

Abstract

BACKGROUND Acne vulgaris often affects the face, shoulders, chest, and back, but treatment of nonfacial acne has not been rigorously studied. OBJECTIVES Assess the safety and efficacy of trifarotene 50 μg/g cream, a novel topical retinoid, in moderate facial and truncal acne. METHODS Two phase III d...

Subject

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!